ESC 365 - Severe cardiotoxicity due to fluoropyrimidines and the rol of the cardio-oncology team

ESC Professional Premium Access

Severe cardiotoxicity due to fluoropyrimidines and the rol of the cardio-oncology team

Session: Cardiac effects of cancer therapies

Topic: Cardio-Oncology

Speaker: Doctor A. GARAY MELERO (Hospitalet De Llobregat, ES)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Alberto GARAY MELERO

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

1 presentation

0 follower

4 more presentations in this session

Cardiac effects of cancer therapies - get ready for the session

Speaker: Associate Professor G. Novo (Palermo, IT)

Drug interctions in cardioncology: a teaching case

Speaker: Doctor D. Garattini (Milan, IT)

The unseen cost of cancer survival: radiation-induced cardiovascular toxicity

Speaker: Doctor M. Loghin-Turturica (Bucharest, RO)

Checkpoint inhibitor-induced triple M syndrome: an uncommon severe presentation of myocarditis, myositis, and myasthenia gravis overlap syndrome

Speaker: Doctor S. Owiredu (Camden, US)

Access the full session

Cardiac effects of cancer therapies

Speakers: Doctor A. GARAY MELERO, Associate Professor G. Novo, Doctor D. Garattini, Doctor M. Loghin-Turturica, Doctor S. Owiredu

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources